Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Purchases of Investments
Cash used to buy marketable securities and other investments.
Purchases of Investments history
Currency unavailable · from the cash flow
No Purchases of Investments data reported for this period type.
Purchases of Investments vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.58B USD | -36.2% | +175.8% | 139.2% | |
VCREVicore Pharma Holding AB | LTM Jun 2026 | SEK 694.08M SEK | +19.1% | — | 52187.6% |
| LTM Mar 2026 | $124M USD | -51.7% | +216.0% | 34.4% | |
| LTM Mar 2026 | $18.51M USD | -27.6% | — | 15.8% | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | -31.9% | +195.9% | 86.8% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.